Association between model for end-stage liver disease and spontaneous bacterial peritonitis

Keith L Obstein1, Mical S Campbell, K Rajender Reddy

  • 1Department of Medicine, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.

Abstract

Insights

Higher Model for End-Stage Liver Disease (MELD) scores significantly increase the risk of spontaneous bacterial peritonitis (SBP) in patients with cirrhosis. This 11% increased risk per MELD point highlights the need for heightened SBP suspicion in high-MELD patients.

Area of Science:

  • Hepatology
  • Infectious Disease Epidemiology
  • Clinical Risk Stratification

Background:

  • Spontaneous bacterial peritonitis (SBP) is a serious complication in patients with cirrhosis and ascites.
  • Early detection and management of SBP are crucial for improving patient outcomes.
  • The Model for End-Stage Liver Disease (MELD) score is a key predictor of mortality in liver disease.

Purpose of the Study:

  • To investigate the association between the Model for End-Stage Liver Disease (MELD) score and the risk of developing spontaneous bacterial peritonitis (SBP).

Main Methods:

  • A retrospective case-control study included 111 patients with cirrhosis and ascites undergoing diagnostic paracentesis.
  • Spontaneous bacterial peritonitis (SBP) was defined by ascitic fluid neutrophil count.
  • Multivariable logistic regression analyzed the odds ratio for SBP development concerning MELD score, adjusting for potential confounders.

Main Results:

  • Patients with SBP had a significantly higher mean MELD score (24) compared to those without SBP (18).
  • Each one-point increase in MELD score was associated with an 11% increased odds of developing SBP.
  • Patients with MELD scores ≥25 had a 9.67-fold increased odds of SBP compared to those with MELD scores ≤15.

Conclusions:

  • Elevated MELD scores are independently associated with an increased risk of spontaneous bacterial peritonitis (SBP) in patients with cirrhosis.
  • The findings underscore the importance of considering SBP in patients presenting with advanced liver disease and high MELD scores.
  • This association has significant clinical implications for patient management and risk stratification.